---
title: "Indoco Remedies Ltd (INDOCO) — Share Price, Financials & Analysis"
symbol: "INDOCO"
company: "Indoco Remedies Ltd"
canonical: "https://tapetide.com/stocks/INDOCO"
isin: "INE873D01024"
nse_symbol: "INDOCO"
bse_code: "532612"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 2356.79
generated_at: "2026-09-13T18:26:25.400Z"
---

# Indoco Remedies Ltd (INDOCO)

Canonical page: https://tapetide.com/stocks/INDOCO

## Company

- **NSE Symbol:** INDOCO
- **BSE Code:** 532612
- **ISIN:** INE873D01024
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2005-01-14
- **CEO:** Mr. Suresh Govind Kare
- **Employees:** 6000
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** indoco.com

## About

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).[1]

## Latest Price

- **Price:** ₹263.02
- **Change:** +8.77 (+3.45%)
- **Open:** ₹260
- **Day High:** ₹276.98
- **Day Low:** ₹251.5
- **Previous Close:** ₹254.25
- **Volume:** 5002402
- **As Of:** 2026-09-11T10:26:58+00:00

## Key Fundamentals

Observed at 2026-09-11T04:49:29.623413Z.

- **Market Cap:** ₹2356.79 Cr
- **Classification:** Microcap
- **P/E (reported):** 747.2
- **P/E (TTM):** 431.18
- **EPS (TTM):** ₹0.61
- **EPS (reported):** ₹7.5
- **Book Value:** ₹101.76
- **Price to Book:** 2.5
- **Dividend Yield:** 0.08%
- **ROE:** -10.59%
- **ROCE:** 1.02%
- **Debt to Equity:** 1.16
- **Revenue (yearly):** ₹1848.6 Cr
- **Net Income:** ₹-98.7 Cr
- **EBITDA:** ₹145.1 Cr
- **52-Week High:** ₹332.2
- **52-Week Low:** ₹162.19
- **RSI (14):** 56.47

## Tapetide Score

- **Score:** 45 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 28.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 15.31 | 9% |
| growth | 42.82 | 9% |
| momentum | 63.49 | 12% |
| ownership | 49.07 | 24% |
| quality | 53.33 | 22% |
| valuation | 41.11 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company's working capital requirements have reduced from 40.8 days to 21.3 days

### Weaknesses

- Stock is trading at 2.58 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 8.25% over past five years.
- Company has a low return on equity of -2.45% over last 3 years.
- Earnings include an other income of Rs.98.3 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 102.48% | 22.67% | 10.59% |
| ebitda margin growth | 313.35% | 25.2% | -43.57% | -63.25% |
| net income growth | 375.95% | 26.54% | -201.75% | -163.76% |
| revenue growth | 23.09% | 10.67% | 3% | 8% |
| roce | 406.74% | -304% | -91.01% | 10.63% |
| roe | -376.35% | 38.43% | -3.17% | -161.89% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 482 | 459 | 450 | 431 | 433 | 411 | 390 | 440 | 485 | 445 | 476 | 468 |
| Expenses | 410 | 397 | 401 | 384 | 392 | 399 | 391 | 422 | 442 | 414 | 426 | 426 |
| Operating Profit | 71 | 63 | 49 | 48 | 40 | 12 | -1 | 18 | 43 | 32 | 50 | 41 |
| OPM % | 15 | 14 | 11 | 11 | 9 | 2.9 | -0.2 | 4 | 9 | 7 | 10 | 9 |
| Other Income | 4 | -6 | 22 | 1 | 2 | 2 | 2 | 2 | 0 | -5 | 4 | 100 |
| Interest | 8 | 10 | 12 | 14 | 18 | 16 | 18 | 26 | 25 | 26 | 46 | 28 |
| Depreciation | 21 | 24 | 26 | 28 | 29 | 29 | 29 | 30 | 32 | 32 | 32 | 35 |
| Profit before tax | 46 | 23 | 33 | 7 | -5 | -31 | -46 | -37 | -14 | -31 | -25 | 78 |
| Tax % | 24 | 31 | 33 | 74 | 107 | -8 | -9 | -1 | -32 | -6 | -5 | 16 |
| Net Profit | 35 | 16 | 22 | 2 | -10 | -28 | -41 | -36 | -9 | -29 | -24 | 65 |
| EPS in Rs | 3.81 | 1.77 | 2.46 | 0.28 | -1.04 | -2.86 | -4.38 | -3.88 | -0.86 | -3.23 | -2.34 | 7.04 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1041 | 968 | 1107 | 1242 | 1541 | 1669 | 1817 | 1665 | 1845 | 1873 |
| Expenses | 906 | 892 | 983 | 1017 | 1213 | 1381 | 1572 | 1565 | 1703 | 1708 |
| Operating Profit | 135 | 77 | 123 | 225 | 328 | 288 | 245 | 100 | 142 | 165 |
| OPM % | 13 | 8 | 11 | 18 | 21 | 17 | 13 | 6 | 8 | 9 |
| Other Income | 5 | 6 | 2 | 3 | 2 | 1 | 20 | 6 | 0 | 98 |
| Interest | 24 | 21 | 26 | 22 | 14 | 25 | 38 | 66 | 122 | 124 |
| Depreciation | 68 | 72 | 71 | 73 | 79 | 71 | 92 | 114 | 126 | 131 |
| Profit before tax | 48 | -9 | 29 | 132 | 237 | 193 | 136 | -74 | -106 | 8 |
| Tax % | 15 | -69 | 16 | 30 | 35 | 26 | 29 | 5 | -7 | — |
| Net Profit | 41 | -3 | 24 | 93 | 155 | 142 | 97 | -78 | -99 | 3 |
| EPS in Rs | 4.47 | -0.31 | 2.62 | 10.1 | 16.8 | 15.44 | 10.68 | -7.99 | -10.31 | 0.61 |
| Dividend Payout % | 22 | -95 | 11 | 15 | 13 | 15 | 14 | -2 | -2 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 633 | 657 | 642 | 661 | 751 | 886 | 1010 | 1091 | 1004 | 921 |
| Borrowings | 280 | 282 | 296 | 262 | 267 | 257 | 333 | 672 | 994 | 1090 |
| Other Liabilities | 266 | 281 | 301 | 330 | 279 | 325 | 297 | 363 | 414 | 564 |
| Total Liabilities | 1197 | 1238 | 1258 | 1272 | 1315 | 1486 | 1658 | 2145 | 2430 | 2593 |
| Fixed Assets | 440 | 489 | 468 | 590 | 570 | 555 | 678 | 954 | 997 | 1193 |
| CWIP | 91 | 136 | 185 | 51 | 68 | 122 | 114 | 125 | 321 | 90 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 1 | 1 |
| Other Assets | 666 | 613 | 605 | 631 | 677 | 809 | 864 | 1057 | 1111 | 1309 |
| Total Assets | 1197 | 1238 | 1258 | 1272 | 1315 | 1486 | 1658 | 2145 | 2430 | 2593 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 89 | 123 | 132 | 123 | 82 | 174 | 179 | 157 | 95 | 192 |
| Cash from Investing Activity | -171 | -135 | -104 | -56 | -67 | -121 | -208 | -433 | -339 | -102 |
| Cash from Financing Activity | 132 | -39 | -16 | -64 | -30 | -44 | 23 | 280 | 241 | -77 |
| Net Cash Flow | 50 | -51 | 12 | 3 | -14 | 8 | -7 | 4 | -3 | 14 |
| Free Cash Flow | -100 | -15 | 39 | 64 | 6 | 49 | -27 | -269 | -257 | 91 |
| CFO/OP | 72 | 98 | 177 | 103 | 45 | 66 | 84 | 76 | 112 | 139 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 74 | 73 | 74 | 69 | 69 | 70 | 77 | 82 | 77 | 97 |
| Inventory Days | 189 | 203 | 209 | 230 | 245 | 248 | 228 | 230 | 307 | 273 |
| Days Payable | 166 | 157 | 195 | 183 | 117 | 107 | 86 | 100 | 152 | 208 |
| Cash Conversion Cycle | 97 | 119 | 88 | 116 | 197 | 212 | 219 | 212 | 232 | 162 |
| Working Capital Days | 41 | 38 | 21 | 22 | 59 | 78 | 82 | 62 | 39 | 21 |
| ROCE % | 12 | 7 | 1 | 6 | 16 | 23 | 17 | 10 | 0 | 1 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 58.74% | 58.74% | 58.72% | 58.75% | 58.75% | 58.8% | 58.9% | 58.9% | 58.9% | 58.9% | 58.86% | 58.86% |
| FIIs | 1.59% | 1.69% | 1.91% | 1.47% | 1.7% | 1.25% | 1.24% | 1.22% | 1.25% | 1.1% | 0.94% | 1.27% |
| DIIs | 17.78% | 19.56% | 19.41% | 18.67% | 18.24% | 18.9% | 18.75% | 18.96% | 18.16% | 18.15% | 18.15% | 17.68% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 16.84% | 15.24% | 15.33% | 16.29% | 16.3% | 16.07% | 15.99% | 15.79% | 16.4% | 16.48% | 16.56% | 16.68% |
| Others | 5.04% | 4.77% | 4.62% | 4.81% | 5.01% | 4.99% | 5.12% | 5.14% | 5.29% | 5.38% | 5.48% | 5.5% |
| No. of Shareholders | 36588 | 32600 | 33201 | 34511 | 34416 | 34676 | 34497 | 33129 | 33319 | 32659 | 32276 | 32457 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 6 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 253.94 | Buy |
| EMA (10) | 250.48 | Buy |
| SMA (20) | 241.01 | Buy |
| EMA (20) | 244.62 | Buy |
| SMA (50) | 237.36 | Buy |
| EMA (50) | 236.93 | Buy |
| SMA (100) | 228.93 | Buy |
| EMA (100) | 231.56 | Buy |
| SMA (200) | 222.52 | Buy |
| EMA (200) | 232.18 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 59.76 | Neutral |
| MACD (12,26,9) | 6.88 | Buy |
| Stochastic (14,3,3) | 46.63 | Neutral |
| ADX (14) | 27 | Buy |
| Williams %R (14) | -34.51 | Neutral |
| ATR (14) | 15.93 | High Volatility |
| ROC (12) | 10.08 | Buy |
| Stoch RSI (14) | 49.88 | Neutral |
| UO (7,14,28) | 41.33 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 0 | 0% |
| Hold | 3 | 75% |
| Sell | 1 | 25% |

Based on 4 analyst ratings, observed at 2026-09-11T04:49:29.749735+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e136ddb-f0be-494e-855d-b1c6225d284f.pdf) |
| 2026-09-10 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4CF12137_E123_41D2_9691_C5FA914680F5_093512.pdf) |
| 2026-09-05 | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9656149c-f67e-4420-bd3f-3e8db2331563.pdf) |
| 2026-09-03 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1F16ECC2_9DEE_413D_A590_D464A58635B1_100751.pdf) |
| 2026-09-01 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C65D054B_5D09_4390_B8C2_389713F33D9F_104644.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fae0fee0-f28f-4407-a5e8-9a89cbefded7.pdf) |
| 2026-08-22 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc1f50ed-0c41-4016-94bf-8f49c3dc1c53.pdf) |
| 2026-08-21 | [Intimation Of Cut-Off Date For E-Voting Book Closure And Record Date For Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f668dccc-15e7-4718-a9d4-100b6a59832a.pdf) |
| 2026-08-21 | [Notice Of 79Th Annual General Meeting And Annual Report For The Financial Year 2025-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68d0d3d8-5c8d-41a8-b5fe-bd76a61cabe8.pdf) |
| 2026-08-21 | [Notice Of 79Th Annual General Meeting And Annual Report For The Financial Year 2025-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af01a020-4932-41cf-b915-18e3bf8e0c68.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a44ee62a-fa72-4d53-8726-1e8ff80dc85c.pdf) |
| 2026-05-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f65f385e-5874-4358-b52d-5d365fa7ad07.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cac5944-8fc0-41df-bcb0-98378bb57601.pdf) |
| 2025-11-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1ef7d09-04d9-46ff-a7b5-c404da807dab.pdf) |
| 2025-07-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99a1bb23-7f1b-414c-9ba7-af6b0b0c6b90.pdf) |
| 2025-05-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50baf8c6-216f-420a-819e-be8049be3653.pdf) |
| 2025-01-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=430d8b36-806b-4bd1-a9a8-ad9b46d4fc2e.pdf) |
| 2024-10-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93ffb66b-6af1-442b-ba0c-e411ae33ff5a.pdf) |
| 2024-07-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d5a3d0a-5ec3-4580-9a68-1b0550b23047.pdf) |
| 2024-05-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3df26b7-2a2b-46c5-b573-04046da47952.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-28 | [Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13e45e59-12e3-4e69-9da8-82f77d2f7b4d.pdf) |
| 2026-05-07 | [Audited Standalone And Consolidated Financial Results For The Quater And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97da8967-a878-41e6-b8d3-60cd164aacb7.pdf) |
| 2026-02-03 | [Financial Results For The Quarter And Nine Months Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ae8a8fe-19b3-4ba1-8b2b-607a8b7e4890.pdf) |
| 2025-11-06 | [Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f5792e5-40e1-415d-acd5-ce82e628d347.pdf) |
| 2025-07-24 | [Financial Results For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f8e8b6a-e757-4bd9-a3d1-589f78c9173c.pdf) |
| 2025-05-22 | [Financial Results For The Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2266188-4c0b-47ad-925d-0f66bc75ae89.pdf) |
| 2025-01-21 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6adca4f6-c7a7-4b22-88be-cd1c1cf91256.pdf) |
| 2024-10-24 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b9f5a52-370d-4b8d-b0f7-adfd9b3ed61e.pdf) |
| 2024-07-23 | [Financial Results For The Quarter Ended 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ab2cdb9-a123-4ad1-be4f-c567534425cb.pdf) |
| 2024-05-16 | [Financial Results For The Quarter And Year Ended 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd9444dc-b780-4102-9512-6180bce30515.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fc5c286-3263-4db5-8daa-ae021c50d06e.pdf) |
| 2026-05-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7d4b5ee-1e80-4759-8487-8e7db2ace4ec.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac6929d2-2815-4901-aebd-89ba65830fdd.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4df9b3a6-57c0-4e70-a809-49417676ceb3.pdf) |
| 2025-07-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c2a8888-f8c9-4bb4-a106-86ba02159c68.pdf) |
| 2025-05-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ae361ec-4fab-42f5-b891-43d48d9be285.pdf) |
| 2024-10-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=212ceada-6a1f-4d0c-b6fd-4003a8223a64.pdf) |
| 2024-07-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1b93fa8-6823-4d5a-acc2-f12533bc5ab3.pdf) |
| 2024-05-16 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f296e224-fd65-49ec-b6fb-62884067b606.pdf) |
| 2024-01-23 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30f31d3c-be67-4134-b062-4ead6cb9c085.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93ffb66b-6af1-442b-ba0c-e411ae33ff5a.pdf) |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d892cc99-53a3-418f-b6d9-96c98185803d.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1ef7d09-04d9-46ff-a7b5-c404da807dab.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/83349b7c-332f-4504-9fdf-26ba22bcc0a0.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f65f385e-5874-4358-b52d-5d365fa7ad07.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/50baf8c6-216f-420a-819e-be8049be3653.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c24f9994-d11b-4282-aa30-fce1a420e686.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3df26b7-2a2b-46c5-b573-04046da47952.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/99a1bb23-7f1b-414c-9ba7-af6b0b0c6b90.pdf) |
| Jul 2024 | [Concall - Jul 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d5a3d0a-5ec3-4580-9a68-1b0550b23047.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December, 2025. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 9 Feb - Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4cac5944-8fc0-41df-bcb0-98378bb57601.pdf) |
| 9 Feb - Maharashtra GST inspection concluded 08 Feb 2026; company provided documents; no official order or material impact. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 9 Feb - Maharashtra GST inspection concluded 08 Feb 2026; company provided documents; no official order or material impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/09391bce-5ddc-4620-a773-9f36478a4979.pdf) |
| 9 Apr - MUFG Intime confirms Regulation 74(5) compliance for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - MUFG Intime confirms Regulation 74(5) compliance for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a5e95cb-df49-47ca-bc30-0de911641fab.pdf) |
| 8 May - Publication of Audited Standalone & Consolidated Financial Results for the Quarter and Year ended 31-03-2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 May - Publication of Audited Standalone & Consolidated Financial Results for the Quarter and Year ended 31-03-2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/548bf6ed-344b-40f7-9f4c-98e9815afa7c.pdf) |
| 7 May - Board approved audited Q4/FY26 standalone and consolidated results; recommended Rs.0.20 dividend per share. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th May, 2026 7 May - Board approved audited Q4/FY26 standalone and consolidated results; recommended Rs.0.20 dividend per share.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e831abf4-9ea9-4eef-9f8c-d8b3fc5ad532.pdf) |
| 7 May - Audio recording of 7 May 2026 earnings call on Q4 and FY26 audited results available online. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 7 May - Audio recording of 7 May 2026 earnings call on Q4 and FY26 audited results available online.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d7d4b5ee-1e80-4759-8487-8e7db2ace4ec.pdf) |
| 4 Feb - Publication of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended 31-12-2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Feb - Publication of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended 31-12-2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/553ed99f-c5e3-47c0-b3b9-4bd119711688.pdf) |
| 31 Mar - Indoco re-appointed Cost Auditor Joshi Apte and Internal Auditor Suresh Surana for FY2026-27 on 31 Mar 2026. | [Announcement Under Regulation 30 Of SEBI LODR-- Intimation Of Re-Appointment Of Cost Auditor And Internal Auditor Of The Company 31 Mar - Indoco re-appointed Cost Auditor Joshi Apte and Internal Auditor Suresh Surana for FY2026-27 on 31 Mar 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/529669cf-6356-45e7-a553-51906b754666.pdf) |
| 30 Apr - Indoco Remedies approved and executed ATB to sell ophthalmic division to Sunways for Rs.110 crore. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 30 Apr - Indoco Remedies approved and executed ATB to sell ophthalmic division to Sunways for Rs.110 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/965ed9e2-6cef-47ad-8742-704d31d8a53e.pdf) |
| 30 Apr - Indoco Remedies approved and executed ATB to sell ophthalmic division to Sunways for Rs.110 crore. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 30 Apr - Indoco Remedies approved and executed ATB to sell ophthalmic division to Sunways for Rs.110 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/965ed9e2-6cef-47ad-8742-704d31d8a53e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d93ac49f-202a-4978-b50e-fa27eb241cf6.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a46f50a-c54d-4629-82bc-ee0864f90932.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14387af4-5ca9-4d1f-bebb-6c07d0212237.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532612/74724532612.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532612/70200532612.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532612/65401532612.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532612/5326120319.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2024-10-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca194bcf-baf8-48e0-9930-b79c57f2487d.pdf) |
| 2024-06-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e71e45d3-9ee6-4679-b314-ff2bbdc7bdae.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:25.400Z.